Novel Markers for Early Detection of Breast Cancer, Diagnostics and Selection of Anti-Cancer Treatment, Delivered by Proteomics and Systems Biology
Serhiy Soulchelnytskyi, Associate Professor, Karolinska Institute, speaking at European Biomarkers Summit 2010.
Looking Forward By Looking Backward: A Possible Step Toward Realization Of Personalized Medicine
Richard Ablin, University of Arizona, speaking at European Biomarkers Summit 2010.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative
In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.
BAC-FISH Assays for Molecular Diagnostics and Cancer Research
Ulli Weier, Staff Scientist, The Histochemical Society, speaking at Molecular Diagnostics World Congress 2009
Metabolic Biomarkers Discovery Project
Vladimir Tolstikov, Director Core Facility, UC Davis, Speaking at Molecular Diagnostics World Congress 2009
Opportunities and Challenges in Multiplexed Diagnostics
Stephen Bodovitz, Principal, Bio Perspectives, speaking at Molecular Diagnostics World Congress 2009
Exploratory Pharmacogenetic Analysis of Efalizumab Responders
Emmanuel Monnet, Head of Biomarker, Merck Serono, speaking at Molecular Diagnostics World Congress 2009
Quantitative Multiplex Analysis Using a Novel Universal Real-time Transcription-Mediated Amplification–based Format
Norman C. Nelson, Director of Biochemistry, Gen-Probe, speaking at Molecular Diagnostics World Congress 2009
Improvement of Sensitivity of Molecular Diagnostics by replacing PCR with Cold-PCR
Mike G. Makrigiorgos, Associate Professor, Director Biophysics Laboratory, Dana Farber Cancer Institute, speaking at Molecular Diagnostics World Congress 2009
|<< || 1 2 3 4 5 ||>>|
|Showing Results 41 - 49 of 49|